US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Superior Pain & Itch Relief

Reason Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-070-05 D-1858-2019
Class II · Moderate risk Terminated

Pre-Tat

Reason Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-019-14 D-1857-2019
Class II · Moderate risk Terminated

Pre-Tat

Reason Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Ridge Properties, LLC NDC 69804-002-05 D-1856-2019
Class II · Moderate risk Terminated

Carbamazepine

Reason Failed Dissolution Specifications

American Health Packaging D-1821-2019
Class II · Moderate risk Terminated

Vivitrol

Reason Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.

Alkermes Inc D-1846-2019
Class II · Moderate risk Terminated

Lisinopril/HCTZ 20mg/12.5mg Tablet

Reason Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.

RemedyRepack Inc. NDC 68180-0519-02 D-1030-2020
Class II · Moderate risk Terminated

Bexarotene Capsules

Reason Failed Dissolution Specifications

Upsher Smith Laboratories, Inc. D-1836-2019
Class II · Moderate risk Terminated

Clear Eyes Redness Relief Hand Pocket Pal Tray Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1835-2019
Class II · Moderate risk Terminated

Clear eyes REDNESS RELIEF

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1834-2019
Class II · Moderate risk Terminated

Clear Eyes Redness Relief Handy Pocket Pal Club Pak Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1833-2019
Class II · Moderate risk Terminated

Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1832-2019
Class II · Moderate risk Terminated

Clear Eyes Maximum Redness Relief Club Pack Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1831-2019
Class II · Moderate risk Terminated

Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1830-2019
Class II · Moderate risk Terminated

Clear Eyes Redness Relief Club Pack Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1829-2019
Class II · Moderate risk Terminated

Clear Eyes Assorted Sidekick Floor Stand Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1828-2019
Class II · Moderate risk Terminated

Clear Eyes Maximum Redness and Itchy Eye Relief Sidekick Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1827-2019
Class II · Moderate risk Terminated

Clear Eyes Assorted IRC Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1826-2019
Class II · Moderate risk Terminated

Clear eyes MAXIMUM REDNESS RELIEF

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1825-2019
Class II · Moderate risk Terminated

Clear eyes MAXIMUM ITCHY EYE RELIEF

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1824-2019
Class II · Moderate risk Terminated

Clear eyes REDNESS RELIEF

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1823-2019
Class II · Moderate risk Terminated

Clear eyes REDNESS RELIEF

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1822-2019
Class II · Moderate risk Terminated

C-Verapamil 2.5mg/Ml Inj Soln

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0034-2020
Class II · Moderate risk Terminated

C-Urea 40% Bladder Instill

Reason Lack of Assurance of Sterility: product sterility cannot be guaranteed.

Colonia Care Pharmacy D-0033-2020